281 related articles for article (PubMed ID: 11579012)
21. Antidepressant use during pregnancy and the risk of major congenital malformations in a cohort of depressed pregnant women: an updated analysis of the Quebec Pregnancy Cohort.
Bérard A; Zhao JP; Sheehy O
BMJ Open; 2017 Jan; 7(1):e013372. PubMed ID: 28082367
[TBL] [Abstract][Full Text] [Related]
22. SSRIs and birth defects.
Kelly MB; Wisner KL; Cornelius MD
Epidemiology; 2007 May; 18(3):411-2; author reply 412-3. PubMed ID: 17435454
[No Abstract] [Full Text] [Related]
23. Antidepressant use in pregnancy and severe cardiac malformations: Danish register-based study.
Kolding L; Ehrenstein V; Pedersen L; Sandager P; Petersen OB; Uldbjerg N; Pedersen LH
BJOG; 2021 Nov; 128(12):1949-1957. PubMed ID: 34036715
[TBL] [Abstract][Full Text] [Related]
24. Antidepressant drug exposure during pregnancy. CZTIS small prospective study.
Manakova E; Hubickova L
Neuro Endocrinol Lett; 2011; 32 Suppl 1():53-6. PubMed ID: 22167208
[TBL] [Abstract][Full Text] [Related]
25. Venlafaxine and nefazodone, two pharmacologically distinct antidepressants.
Augustin BG; Cold JA; Jann MW
Pharmacotherapy; 1997; 17(3):511-30. PubMed ID: 9165554
[TBL] [Abstract][Full Text] [Related]
26. Pregnancy outcome following maternal exposure to mirtazapine: a multicenter, prospective study.
Winterfeld U; Klinger G; Panchaud A; Stephens S; Arnon J; Malm H; Te Winkel B; Clementi M; Pistelli A; Maňáková E; Eleftheriou G; Merlob P; Kaplan YC; Buclin T; Rothuizen LE
J Clin Psychopharmacol; 2015 Jun; 35(3):250-9. PubMed ID: 25830592
[TBL] [Abstract][Full Text] [Related]
27. Emergence of adverse events following discontinuation of treatment with extended-release venlafaxine.
Fava M; Mulroy R; Alpert J; Nierenberg AA; Rosenbaum JF
Am J Psychiatry; 1997 Dec; 154(12):1760-2. PubMed ID: 9396960
[TBL] [Abstract][Full Text] [Related]
28. Safety of newer antidepressants in pregnancy.
Way CM
Pharmacotherapy; 2007 Apr; 27(4):546-52. PubMed ID: 17381382
[TBL] [Abstract][Full Text] [Related]
29. Venlafaxine-induced hair loss.
Pitchot W; Ansseau M
Am J Psychiatry; 2001 Jul; 158(7):1159-60. PubMed ID: 11431245
[No Abstract] [Full Text] [Related]
30. Exposure to selective serotonin reuptake inhibitors in early pregnancy and the risk of miscarriage.
Andersen JT; Andersen NL; Horwitz H; Poulsen HE; Jimenez-Solem E
Obstet Gynecol; 2014 Oct; 124(4):655-661. PubMed ID: 25198261
[TBL] [Abstract][Full Text] [Related]
31. Effects of first-trimester fluoxetine exposure on the newborn.
Goldstein DJ; Corbin LA; Sundell KL
Obstet Gynecol; 1997 May; 89(5 Pt 1):713-8. PubMed ID: 9166307
[TBL] [Abstract][Full Text] [Related]
32. Birth outcomes in pregnant women taking fluoxetine.
Chambers CD; Johnson KA; Dick LM; Felix RJ; Jones KL
N Engl J Med; 1996 Oct; 335(14):1010-5. PubMed ID: 8793924
[TBL] [Abstract][Full Text] [Related]
33. Safety of haloperidol and penfluridol in pregnancy: a multicenter, prospective, controlled study.
Diav-Citrin O; Shechtman S; Ornoy S; Arnon J; Schaefer C; Garbis H; Clementi M; Ornoy A
J Clin Psychiatry; 2005 Mar; 66(3):317-22. PubMed ID: 15766297
[TBL] [Abstract][Full Text] [Related]
34. Pregnancy outcome of women exposed to bupropion during pregnancy: a prospective comparative study.
Chun-Fai-Chan B; Koren G; Fayez I; Kalra S; Voyer-Lavigne S; Boshier A; Shakir S; Einarson A
Am J Obstet Gynecol; 2005 Mar; 192(3):932-6. PubMed ID: 15746694
[TBL] [Abstract][Full Text] [Related]
35. Selective serotonin reuptake inhibitor use during pregnancy and possible neonatal complications.
Cantor Sackett J; Weller RA; Weller EB
Curr Psychiatry Rep; 2009 Jun; 11(3):253-7. PubMed ID: 19470288
[TBL] [Abstract][Full Text] [Related]
36. A double-blind comparison of escitalopram and venlafaxine extended release in the treatment of major depressive disorder.
Bielski RJ; Ventura D; Chang CC
J Clin Psychiatry; 2004 Sep; 65(9):1190-6. PubMed ID: 15367045
[TBL] [Abstract][Full Text] [Related]
37. Effect of prenatal selective serotonin reuptake inhibitor (SSRI) exposure on birthweight and gestational age: a sibling-controlled cohort study.
Nezvalová-Henriksen K; Spigset O; Brandlistuen RE; Ystrom E; Koren G; Nordeng H
Int J Epidemiol; 2016 Dec; 45(6):2018-2029. PubMed ID: 27188860
[TBL] [Abstract][Full Text] [Related]
38. Increase in use of selective serotonin reuptake inhibitors in pregnancy during the last decade, a population-based cohort study from the Netherlands.
Bakker MK; Kölling P; van den Berg PB; de Walle HE; de Jong van den Berg LT
Br J Clin Pharmacol; 2008 Apr; 65(4):600-6. PubMed ID: 17953715
[TBL] [Abstract][Full Text] [Related]
39. Hyponatraemia in elderly psychiatric patients treated with Selective Serotonin Reuptake Inhibitors and venlafaxine: a retrospective controlled study in an inpatient unit.
Kirby D; Harrigan S; Ames D
Int J Geriatr Psychiatry; 2002 Mar; 17(3):231-7. PubMed ID: 11921151
[TBL] [Abstract][Full Text] [Related]
40. Venlafaxine-associated hypomania in unipolar depression.
Chand PK; Kalyani GS; Murthy P
Can J Psychiatry; 2004 Jul; 49(7):496. PubMed ID: 15362257
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
